Left Atrial Appendage Exclusion

Exclusion of the left atrial appendage has acquired a role as an effective approach to reduce the thromboembolic risk related to atrial fibrillation in patients who are deemed to be poor long term candidates for oral anticoagulation. Because of the invasive nature and morbidity associated with surgical exclusion, percutaneous approaches have progressively gained momentum over the last years. We describe device related technical details as well procedural aspects of the most commonly used of these devices.

References

Watson T , Shantsila E , Lip GY . Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited . The Lancet 2009 ; 373 : 155 – 166 .
10.1016/S0140-6736(09)60040-4
CAS PubMed Web of Science® Google Scholar
January CT , L. Wann S, Alpert JS , et al . 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society . J Am Coll Cardiol 2014 ; 64 : e1 – 76 .
10.1016/j.jacc.2014.03.022
PubMed Web of Science® Google Scholar
Granger CB , Armaganijan LV . Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism . Circulation 2012 ; 125 : 159 – 164 .
10.1161/CIRCULATIONAHA.111.031146
PubMed Web of Science® Google Scholar
Holmes DR , Reddy VY , Turi ZG , et al . Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial . The Lancet 2009 ; 374 : 534 – 542 .
10.1016/S0140-6736(09)61343-X
CAS PubMed Web of Science® Google Scholar
Holmes DR Jr , Kar S , Price MJ , et al . Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial . J Am Coll Cardiol 2014 ; 64 ( 1 ): 1 – 12 .
10.1016/j.jacc.2014.04.029
PubMed Web of Science® Google Scholar
Faxon D , Eikelboom J , Berger P , et al . Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North American perspective . Thromb Haemost 2011 ; 106 : 572 – 584 .
10.1160/TH11-04-0262
CAS PubMed Web of Science® Google Scholar
Fountain RB , Holmes DR , Chandrasekaran K , et al . The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial . Am Heart J 2006 ; 151 : 956 – 961 .
10.1016/j.ahj.2006.02.005
PubMed Web of Science® Google Scholar
Reddy VY , Holmes D , Doshi SK . The safety of percutaneous left atrial appendage closure: results from PROTECT AF and the Continued Access Registry . Circulation 2011 ; 123 : 417 – 424 .
10.1161/CIRCULATIONAHA.110.976449
PubMed Web of Science® Google Scholar
Reddy VY , Doshi SK , Sievert H , et al . Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial . Circulation 2013 ; 127 : 720 – 729 .
10.1161/CIRCULATIONAHA.112.114389
PubMed Web of Science® Google Scholar
Freeman JV , Varosy P , Price MJ , et al . The NCDR Left Atrial Appendage Occlusion Registry . J Am Coll Cardiol. 2020 Apr, 75 ( 13 ) 1503 – 1518 .
10.1016/j.jacc.2019.12.040
PubMed Web of Science® Google Scholar
Urena M , Rodés-Cabau J , Freixa X , et al . Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy . J Am Coll Cardiol 2013 ; 62 ( 2 ): 96 – 102 .
10.1016/j.jacc.2013.02.089
PubMed Web of Science® Google Scholar
Freixa X1 , Chan JL , Tzikas A , et al . The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience . EuroIntervention 2013 ; 8 ( 9 ): 1094 – 1098 .
10.4244/EIJV8I9A167
PubMed Web of Science® Google Scholar
Meier B , Blaauw Y , Khattab AA , et al . EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion . Europace 2014 ; 16 : 1397 – 1416 .
10.1093/europace/euu174
PubMed Web of Science® Google Scholar
Abualsaud A , Freixa X , Tzikas A , et al . Side-by-side comparison of LAA occlusion performance with the Amplatzer cardiac plug and Amplatzer Amulet . J Invasive Cardiol. 2016 ; 28 : 34 – 38 .
PubMed Web of Science® Google Scholar
Ailawadi G , Gerdisch MW , Harvey RL , et al . Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial . Cardiovasc Surg . 2011 Nov; 142 ( 5 ): 1002 – 9 , 1009.
Google Scholar
Regueiro A , Bernier M , O'Hara G , et al . Left atrial appendage closure: Initial experience with the ultraseal device . J. Catheter Cardiovasc Interv. 2017 Nov 1; 90 ( 5 ): 817 – 823 .
10.1002/ccd.26870
PubMed Web of Science® Google Scholar
Freixa X , Aminian A , Tzikas A. et al . Left atrial appendage occlusion with the Amplatzer Amulet: update on device sizing . J Interv Card Electrophysiol. 2020 . https://doi.org/10.1007/s10840-019-00699-5 .
Google Scholar
Shetty R , Leitner J , Zhang M . Percutaneous catheter-based left atrial appendage ligation and management of periprocedural left atrial appendage perforation with the LARIAT suture delivery system . J Invasive Cardiol 2012 ; 24 : E289 – 293 .
PubMed Web of Science® Google Scholar
Turagam MH , Vuddanda V , Verberkmoes N , et al . Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension . J Am Coll Cardiol , Vol 72 , 12 , 2018 , 1346 – 1353 .
10.1016/j.jacc.2018.06.066
PubMed Web of Science® Google Scholar
Cilingiroglu M , Salinger M , Zhao D , Feldman T . Technique of temporary subcutaneous “Figure-of-eight” sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths . Catheter Cardiovasc Interv 2011 ; 78 ( 1 ): 155 – 160 .
10.1002/ccd.22946
CAS PubMed Web of Science® Google Scholar
Reddy VY , Möbius-Winkler S , Miller MA , et al . Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology (ASAP Study) . J Am Coll Cardiol 2013 ; 61 : 2551 – 2556 .
10.1016/j.jacc.2013.03.035
PubMed Web of Science® Google Scholar
Gu ZC , Qiao ZQ , Hao ZY , et al . Initial anticoagulation experience with standard-dose rivaroxaban after Watchman left atrial appendage occlusion . Ann Transl Med. 2020 ; 8 ( 4 ): 105 .
10.21037/atm.2019.12.116
CAS PubMed Google Scholar
Park J , Bethencourt A , Sievert H , et al . Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation: initial European experience . Catheter Cardiovasc Interv 2011 ; 77 : 700 – 706 .
10.1002/ccd.22764
PubMed Web of Science® Google Scholar
Krumsdorf U , Ostermayer S , Billinger K , et al . Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients . J Am Coll Cardiol 2004 ; 43 : 302 – 309 .
10.1016/j.jacc.2003.10.030
PubMed Web of Science® Google Scholar
Tzikas A , Shakir S , Gafoor S , et al . Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug . EuroIntervention. 2016 Feb; 11 ( 10 ): 1170 – 9 .
10.4244/EIJY15M01_06
PubMed Web of Science® Google Scholar
Pillarisetti J , Reddy YM , Gunda S , et al . Endocardial (Watchman) versus epicardial (Lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications . Heart Rhythm 2015 ; 12 : 1501 – 1507 .
10.1016/j.hrthm.2015.03.020
PubMed Web of Science® Google Scholar

Interventional Cardiology: Principles and Practice, Third Edition